Medical cannabis

Medical cannabis – the evolving law and innovation in treatment

The developing legal approach in the UK to medical cannabis highlights the problems law makers have in responding adequately to clinical and technological advances: especially those that challenge conventional views. This has arguably stifled innovation in medical cannabis research in the UK, and prevented patients from receiving worthwhile treatments. This

Share our insights
Continue reading
Lobbying Scottish Parliament

Lobbying in Scotland from March 2018 – new rules briefing

The new lobbying rules in Scotland do not just apply to professional lobbyists. Face to face discussions about government functions with Scottish Government ministers, MSPS or senior civil servants will be  caught by the rules.  These discussions will need to be reported on the Lobbying Register. It’s straightforward to use the Lobbying Register but you need to know whether

Share our insights
Continue reading

Regulating disruptive technology – are you an activist or a sceptic?

In his interview with the FT, published earlier this week, Jochen Homann, president of Germany’s Bundesnetzagentur or Federal Networks Authority, underlines his determination that US tech giants, such as Google and Facebook (and their services, such as Gmail and WhatsApp), should be regulated like conventional telecoms firms.  As he puts

Share our insights
Continue reading
Supreme Court cell phone data

My data, your data? The US Supreme Court puzzles over the fundamental rights status of third-party personal data

In a world in which personal data is increasingly held, and indeed generated by, third parties (social media firms, financial institutions and utilities), it is becoming increasingly important to establish what our legal relationship to that third-party controlled personal data (TCPD) actually is, not only in terms of data protection

Share our insights
Continue reading